¼¼°èÀÇ Áý´Ü°Ç°­°ü¸® ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®(Á¦Ç°º°, ¹èÆ÷ ¸ðµå, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°), Àü¸Á, ¿¹Ãø(2025-2032³â)
Global Population Health Management Market Size, Share & Industry Analysis Report By Product, By Delivery Mode, By End-use, By Regional Outlook and Forecast, 2025 - 2032
»óǰÄÚµå : 1804071
¸®¼­Ä¡»ç : KBV Research
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 445 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,600 £Ü 5,052,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,320 £Ü 6,062,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,048 £Ü 8,487,000
PDF (Corporate User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Áý´Ü°Ç°­°ü¸® ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ µ¿¾È 21.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³»°í 2032³â±îÁö 3,920¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖ¿ä ÇÏÀ̶óÀÌÆ® :

Áý´Ü°Ç°­°ü¸®´Â Ä¿¹Â´ÏƼ ¼öÁØÀÇ Á¤º¸¿Í ÀÓ»ó Áö½ÄÀ» ÅëÇÕÇÏ´Â µ¥ÀÌÅÍ Áß½ÉÀÇ ºÐ¾ß·Î ÁøÈ­ÇØ ¿Ô½À´Ï´Ù. Áý´Ü°Ç°­°ü¸®(PHM)´Â û±¸ ÅëÇÕ, »óÈ£ ¿î¿ë °¡´ÉÇÑ ½Ã½ºÅÛ, ÀüÀÚ ÀÇ·á ±â·Ï µîÀÇ ±â´ÉÀ» Ȱ¿ëÇÏ¿© Äɾî Á¦°øÀ» »çÈÄ ´ëÀÀÇü¿¡¼­ ¿¹¹æÇü ¸®½ºÅ© Ä¡·á·Î º¯È¯Çß½À´Ï´Ù. ÀÇ·á±â°ü°ú Á¤ºÎ´Â ºÐ¼®À» ÀÌ¿ëÇÏ¿© ÄɾîÀÇ °ÝÂ÷¸¦ ÆÄ¾ÇÇϰí, °³ÀÔÀ» Á¶Á¤Çϰí, À§ÇèÀ» °èÃþÈ­ÇÏ´Â ¿î¿µ ¸ðµ¨·Î¼­ PHMÀ» ÇコÄɾ µµÀÔÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº Àα¸ µî·Ï, ÀÚµ¿È­µÈ ¿öÅ©Ç÷οì, Æó¼âÇü ·çÇÁ ¼Ò°³ ±â´ÉÀ» °®Ãá Ç÷§ÆûÀ» µµÀÔÇÏ¿© ÀÇ·á Á¦»ê¾÷üÀÇ °ÝÂ÷ ½ÃÁ¤, ¿¹¹æ È¿°ú Çâ»ó, ¾Æ¿ô¸®Ä¡ È¿À²È­¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.

ÃÖ±Ù Áý´Ü°Ç°­°ü¸®´Â °øÁß º¸°Ç ¸ñÇ¥¿Í °Ç°­ °ü¸® ¸ÞÄ¿´ÏÁòÀ» À¶ÇÕ½ÃŲ °³³äÀ¸·Î ¹ßÀüÇØ ¿ÔÀ¸¸ç, ¸¸¼º Áúȯ, °í·ÉÈ­ ¹× °¡Ä¡ ±â¹Ý °è¾à¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ±×Á߿伺ÀÌ Á¡Â÷ Ä¿Áö°í ÀÖ½À´Ï´Ù. ½ÃÀå °ü°èÀÚ´Â ¿ø°Ý ¸ð´ÏÅ͸µ, ¿öÅ©Ç÷οì ÀÚµ¿È­ ¹× ȯÀÚ Âü¿©¸¦ °áÇÕÇÏ¿© PHM¿¡¼­ ¾òÀº ÀλçÀÌÆ®·ÂÀ» ÃøÁ¤ °¡´ÉÇÑ ¼º°ú·Î ¿¬°áÇÕ´Ï´Ù. ¿î¿µ ±â´É, ÀÔÁõµÈ ¼º°ú, »óÈ£ ¿î¿ë¼ºÀ» ½ÇÇöÇÏ´Â PHM¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå °æÀïÀÌ Ä¡¿­ÇØÁö°í ÀÖ½À´Ï´Ù. Á¤ºÎ°¡ ¾÷°è¸¦ °¡·ÎÁö¸£´Â µ¥ÀÌÅÍ °øÀ¯¿Í Ç¥ÁØÈ­µÈ ÁöÇ¥¿¡ ´ëÇÑ ÁÖ·ÂÀ» °­È­ÇÏ´Â °¡¿îµ¥ Áý´Ü°Ç°­°ü¸®´Â µðÁöÅÐ µµ±¸, ÀÓ»ó ÄÉ¾î ¹× »çȸ º¹Áö ¼­ºñ½º¸¦ ÅëÇÕÇÏ´Â ÅëÇÕ Ç÷§Æû°ú À¶ÇÕÇÏ¿© ÀϽÃÀûÀÎ Ä¡·á °³³äÀ» Áö¼ÓÀûÀÎ °Ç°­ °ü¸®·Î º¯È­½Ã۰í ÀÖ½À´Ï´Ù.

KBV Cardinal matrix¿¡ Á¦½ÃµÈ ºÐ¼®¿¡ µû¸£¸é Optum, Inc.¿Í Oracle CorporationÀº Áý´Ü°Ç°­°ü¸® ½ÃÀåÀÇ ¼±±¸ÀÚÀÔ´Ï´Ù. IBM Corporation ¹× McKesson Corporation°ú °°Àº ±â¾÷Àº Áý´Ü°Ç°­°ü¸® ½ÃÀåÀÇ ÁÖ¿ä Çõ½ÅÀÚÀÔ´Ï´Ù. 2022³â 4¿ù IBM CorporationÀº ÇコÄÉ¾î Æ®·£½ºÆ÷¸ÞÀÌ¼Ç ÄÁ¼Ò½Ã¾ö°ú Á¦ÈÞÇÏ¿© AI¸¦ Ȱ¿ëÇÑ Àα¸°Ç°­ºÐ¼®À» Á¦°øÇϱ⠽ÃÀÛÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ³ë·ÂÀ» ÅëÇØ º´¿øÀº ¿¹Ãø ¸ðµ¨°ú »çȸÀû °áÁ¤ ¿äÀÎ µ¥ÀÌÅ͸¦ Ȱ¿ëÇÏ¿© Áö¿ª ¼öÁØÀÇ °Ç°­ ¼º°ú¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇ⠺м®

COVID-19 ÆÒµ¥¹ÍÀº Àû±ØÀûÀÌ°í µ¥ÀÌÅÍ ±â¹Ý Äɾ¼­ Áý´Ü°Ç°­°ü¸®ÀÇ Á߿伺À» °­Á¶ÇÏ°í µµÀÔÀ» °¡¼ÓÈ­Çß½À´Ï´Ù. PHM µµ±¸´Â ÀÇ·á ½Ã½ºÅÛ¿¡¼­ ¹Î°¨ÇÑ ±×·ìÀ» ¸ð´ÏÅ͸µÇϰí, °Ë»ç, ¿¹¹æ Á¢Á¾, Ä¡·á¸¦ °ü¸®Çϰí, ´Ù¾çÇÑ ÃâóÀÇ Á¤º¸¸¦ ÅëÇÕÇÏ¿© ½Å¼ÓÇÑ ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ »ç¿ëµÇ¾ú½À´Ï´Ù. °øÁ¤¼ºÀ» ³ôÀÌ°í °ÝÂ÷¸¦ ÁÙÀÌ´Â ÁýÁßÀûÀÎ °³ÀÔÀ» ÀÌÇàÇϱâ À§ÇØ ÀÌ À§±â´Â °Ç°­ÀÇ »çȸÀû °áÁ¤ ¿äÀο¡ ´ëÇÑ ³ë·Â¿¡ ÁßÁ¡À» µÎ¾ú½À´Ï´Ù. ±Þ¼ÓÇÑ µðÁöÅÐ º¯ÇõÀº COVID-19¿¡ ¸Â´Â ¿ø°Ý ÀÇ·á, ¿ø°Ý ¸ð´ÏÅ͸µ, ´ë½Ãº¸µå¸¦ Á¦°øÇÏ¿© À§±â ´ëÀÀ ¹× °ü¸® Á¦°øÀ» °³¼±Çß½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº PHMÀÌ ¿î¿µÀÇ È¿´É°ú Áï°¢¼º¿¡ ±â¿©ÇÑ´Ù´Â °ÍÀ» ÀÔÁõÇßÀ¸¸ç, ±¹Á¦ °Ç°­ °ü¸® ½Ã½ºÅÛ Àü¹Ý¿¡ °ÉÄ£ Àå±âÀûÀÎ ÅõÀÚ¿Í µµÀÔÀ» ÃËÁøÇß½À´Ï´Ù. µû¶ó¼­ COVID-19´Â ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

Á¦Ç°º° Àü¸Á

Á¦Ç°º°·Î º¼ ¶§ Áý´Ü°Ç°­°ü¸® ½ÃÀåÀº ¼­ºñ½º ¹× ¼ÒÇÁÆ®¿þ¾î·Î ºÐ·ùµË´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ºÎ¹®Àº 2024³â ½ÃÀå Á¡À¯À²ÀÇ 47%¸¦ Â÷ÁöÇß½À´Ï´Ù. ÀÌ·¯ÇÑ Ç÷§ÆûÀ» ÅëÇØ °Ç°­°ü¸® ÀÌÇØ°ü°èÀÚ´Â ÀÓ»ó µ¥ÀÌÅÍ, û±¸ µ¥ÀÌÅÍ, »çȸÀû °áÁ¤ ¿äÀÎ µ¥ÀÌÅ͸¦ ¼öÁý, ÅëÇÕ, ºÐ¼®ÇÏ°í ¾òÀº Áö½ÄÀ» ½Ç¿ëÀûÀÎ Äɾî Ç÷£¿¡ ¹Ý¿µÇÒ ¼ö ÀÖ½À´Ï´Ù. PHM ¼ÒÇÁÆ®¿þ¾î¿¡´Â Á¾Á¾ ȯÀÚ µî·Ï, ÄÉ¾î °¸ °æ°í, Äɾî ÄÚµð³×ÀÌ¼Ç ´ë½Ãº¸µå, ǰÁú ÁöÇ¥ º¸°í µµ±¸ µîÀÇ ¸ðµâÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ¸¹Àº ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀº ÀüÀÚ °Ç°­ ±â·Ï(EHR) ¹× ±âŸ ÀÇ·á IT ½Ã½ºÅÛ°ú ÅëÇյǵµ·Ï ¼³°èµÇ¾úÀ¸¸ç Áý´Ü °Ç°­ Àü·«À» °ü¸®Çϱâ À§ÇÑ Áß¾Ó È¯°æÀ» Á¦°øÇÕ´Ï´Ù.

Á¦°ø ¹æ½Äº° Àü¸Á

Á¦°ø ÇüÅ¿¡ µû¶ó Áý´Ü°Ç°­°ü¸® ½ÃÀåÀº Ŭ¶ó¿ìµå ±â¹Ý°ú On-PremiseÀÇ µÎ °¡Áö·Î ºÐ·ùµË´Ï´Ù. On-Premise ºÎ¹®Àº 2024³â ½ÃÀå Á¡À¯À²ÀÇ 27%¸¦ Â÷ÁöÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ On-Premise Á¦°ø ÇüÅ´ ÀÎÇÁ¶ó, µ¥ÀÌÅÍ º¸¾È ¹× ½Ã½ºÅÛ ¸ÂÃãÈ­¿¡ ´ëÇÑ Á÷Á¢ÀûÀÎ Á¦¾î¸¦ Áß½ÃÇÏ´Â ÀÇ·á ±â°ü¿¡ °è¼Ó ±â¿©Çß½À´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ ÀÇ·á±â°üÀº ¾ö°ÝÇÑ ±ÔÁ¤ Áؼö ¿ä±¸»çÇ× ¹× ³»ºÎ °Å¹ö³Í½º Á¤Ã¥À» ÁؼöÇϸ鼭 ¹Î°¨ÇÑ ÀÇ·á Á¤º¸¸¦ ÀÚü µ¥ÀÌÅͼ¾ÅÍ¿¡ ÀúÀåÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. On-Premise ¼Ö·ç¼ÇÀº »ç¿ëÀÚ Á¤ÀÇµÈ ±¸¼ºÀ» ´õ ¸¹ÀÌ Á¦°øÇÏ¿© Á¶Á÷ÀÌ ½Ã½ºÅÛÀ» ƯÁ¤ ¿öÅ©Ç÷Π¹× ÅëÇÕ ¿ä±¸¿¡ ¸Â°Ô ÀûÀÀ½Ãų ¼ö ÀÖ¾ú½À´Ï´Ù.

Áö¿ªº° Àü¸Á

Áö¿ªº°·Î º¸¸é Áý´Ü°Ç°­°ü¸® ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, LAMEA¿¡¼­ ºÐ¼®µÇ°í ÀÖ½À´Ï´Ù. ºÏ¹Ì ºÎ¹®Àº 2024³â ½ÃÀå¿¡¼­ 44%ÀÇ ¼öÀÍ Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù. ºÏ¹Ì¿¡¼­´Â Áý´Ü°Ç°­°ü¸® ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. À̰ÍÀº °Ç°­ °ü¸® ±¸Á¶ÀÇ °­È­¿Í ÀüÀÚ °Ç°­ ±â·ÏÀÇ º¸±Þ ¶§¹®ÀÔ´Ï´Ù. ½ÃÀå ¼ºÀåÀº ¹Ì±¹°ú °°Àº ±¹°¡¿¡¼­ µÎµå·¯Áö¸ç ȯÀÚ °á°ú¸¦ Çâ»ó½ÃŰ¸é¼­ °Ç°­ °ü¸® ºñ¿ëÀ» ÁÙÀÌ´Â µ¥ ÁßÁ¡À» µÓ´Ï´Ù. ¶ÇÇÑ µðÁöÅÐ Çコ Ç÷§Æû ä¿ë Áõ°¡µµ È®´ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯·´¿¡¼­´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ±âȸ¸¦ º¼ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´ÀÇ ¼ºÀåÀº °Ç°­ °ü¸®ÀÇ µðÁöÅÐÈ­¸¦ Áö¿øÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê, ¿¹¹æ ÀÇ·á¿¡ ÁßÁ¡À» µÎ°í, ³ëÈ­ ¹× ¸¸¼º ÁúȯÀ» °ü¸®ÇÏ´Â PHM ¼Ö·ç¼ÇÀÇ µµÀÔÀ¸·Î ÃßÁøµÇ°í ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­ Áý´Ü°Ç°­°ü¸® ½ÃÀåÀº ²ÙÁØÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ´Â ¸¸¼ºÁúȯ¿¡ ´ëÇÑ °ü½É Áõ°¡, ÇコÄÉ¾î ºñ¿ë Áõ°¡, ÀϺ», Àεµ, Áß±¹ µîÀÇ ±¹°¡¿¡¼­ÀÇ µðÁöÅÐ ÇコÄɾîÀÇ º¸±Þ¿¡ ÀÇÇÑ °ÍÀÔ´Ï´Ù. ÇコÄɾî IT¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í Á¤ºÎ ÁÖµµÀÇ ÇコÄÉ¾Æ ÀÌ´Ï¼ÅÆ¼ºê´Â »ç¶÷µéÀÇ ¼ö¿ëµµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, LAMEA ½ÃÀåÀº °Ç°­ °ü¸® ½Ã½ºÅÛÀÇ Çö´ëÈ­¿Í ¼¼°è ÀÇ·á Á¦»ê¾÷ü¿ÍÀÇ Çù·Â Áõ°¡·Î À¯¸ÁÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ºñ¿ë È¿À²ÀûÀ̰í È¿À²ÀûÀÎ ÄÉ¾î ¸ðµ¨¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ÀÌ·¯ÇÑ ¼ºÀåÀ» Áö¿øÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀåÀÇ ¹üÀ§¿Í ºÐ¼® ¼ö¹ý

Á¦2Àå ½ÃÀå °³°ü

Á¦3Àå ½ÃÀå °³¿ä

Á¦4Àå ½ÃÀå µ¿Çâ : Áý´Ü°Ç°­°ü¸® ½ÃÀå

Á¦5Àå °æÀï ±¸µµ : Áý´Ü°Ç°­°ü¸® ½ÃÀå

Á¦6Àå Á¦Ç° ¶óÀÌÇÁ »çÀÌŬ(PLC) : Áý´Ü°Ç°­°ü¸® ½ÃÀå

Á¦7Àå ½ÃÀå ÅëÇÕ : Áý´Ü°Ç°­°ü¸® ½ÃÀå

Á¦8Àå °æÀï ºÐ¼® : ¼¼°è ½ÃÀå

Á¦9Àå ¹ë·ùüÀÎ ºÐ¼® : Áý´Ü°Ç°­°ü¸® ½ÃÀå

Á¦10Àå ÁÖ¿ä °í°´ ±âÁØ : Áý´Ü°Ç°­°ü¸® ½ÃÀå

Á¦11Àå ¼¼°èÀÇ Áý´Ü°Ç°­°ü¸® ½ÃÀå : Á¦Ç°º°

Á¦12Àå ¼¼°èÀÇ Áý´Ü°Ç°­°ü¸® ½ÃÀå : Á¦°ø ¹æ½Äº°

Á¦13Àå ¼¼°èÀÇ Áý´Ü°Ç°­°ü¸® ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

Á¦14Àå ¼¼°èÀÇ Áý´Ü°Ç°­°ü¸® ½ÃÀå : Áö¿ªº°

Á¦15Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦16Àå Áý´Ü°Ç°­°ü¸® ½ÃÀå ¼º°ø Çʼö Á¶°Ç

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Population Health Management Market size is expected to reach USD 392.09 billion by 2032, rising at a market growth of 21.6% CAGR during the forecast period.

Key Highlights:

Population health management has evolved as a data-driven discipline that integrates community-level information with clinical insights. PHM has transformed care delivery to proactive risk management from reactive treatment with the capabilities of claims integration, interoperable systems, and electronic health records. Health organizations as well as governments are both deploying PHM into healthcare as an operational model using analytics to identify care gaps, coordinate interventions, and stratify risk. Key players in the market are introducing platforms that offer population registries, automated workflows, and closed-loop referrals to support providers in reducing disparities, enhancing preventive outcomes, and streamlining outreach.

These days, population health management has become a concept combining public health goals with healthcare delivery mechanics, strengthened by the growing concern of chronic diseases, aging population, and value-based contracting. Players in the market now combine remote monitoring, workflow automation, and patient engagement to make sure that insights driven through PHM can be translated to measurable results. Market competition is increasing with demand for PHM enabling operational functionality, demonstrated outcomes, and interoperability. With increasing focus of governments towards cross-industry data sharing and standardized measures, population health management is combining with integrated platforms that consolidate digital tools, clinical care, and social services, thereby transforming the concept of episodic treatment to continued health management.

The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. In March, 2025, Athenahealth, Inc. partnered with GRAIL to integrate Galleri(R) cancer screening into its EHR platform, enabling streamlined early cancer detection for high-risk populations. This collaboration supports preventive care and broad adoption of population health strategies. Additionally, In July, 2024, eClinicalWorks LLC and Aledade partnered to integrate Sunoh.ai, an AI-powered ambient listening tool, improving clinical documentation and physician efficiency. This collaboration enhances value-based care, streamlines workflows, and supports population health management across over 400 jointly supported primary care practices.

Based on the Analysis presented in the KBV Cardinal matrix; Optum, Inc. and Oracle Corporation and are the forerunners in the Population Health Management Market. Companies such as IBM Corporation and McKesson Corporation are some of the key innovators in the Population Health Management Market. In April, 2022, IBM Corporation partnered with the Healthcare Transformation Consortium to deliver AI-powered population health analytics. The initiative enables hospitals to use predictive models and social determinants data to improve health outcomes at the community level.

COVID 19 Impact Analysis

By emphasizing the importance of population health management (PHM) in proactive, data-driven care, the COVID-19 pandemic hastened its adoption. PHM tools were used by health systems to monitor susceptible groups, control testing, immunization, and treatment, and combine information from various sources to make prompt decisions. To implement focused interventions that increased equity and decreased disparities, the crisis placed a strong emphasis on addressing social determinants of health. Telehealth, remote monitoring, and dashboards tailored to COVID-19 were brought about by rapid digital transformation, which improved crisis response and care delivery. These innovations demonstrated PHM's contribution to operational effectiveness and readiness, promoting long-term investment and adoption throughout international healthcare ecosystems. Thus, the COVID-19 had a positive impact on the market.

Product Outlook

Based on Product, the Population Health Management Market is segmented into Services, and Software. The Software segment acquired 47% revenue share in the market in 2024. These platforms enable healthcare stakeholders to collect, integrate, and analyze clinical, claims, and social determinants data, translating insights into actionable care plans. PHM software often includes modules for patient registries, gaps-in-care alerts, care coordination dashboards, and reporting tools for quality measures. Many software solutions are designed to integrate with electronic health records and other health IT systems, offering a centralized environment for managing population health strategies.

Delivery Mode Outlook

Based on Delivery Mode, the Population Health Management Market is segmented into Cloud-based, and On-Premise. The On-Premise segment acquired 27% revenue share in the market in 2024. The on-premise delivery mode in this market continued to serve healthcare organizations that prioritized direct control over their infrastructure, data security, and system customization. This approach enabled institutions to maintain sensitive health information within their own data centers, aligning with strict compliance requirements and internal governance policies. On-premise solutions offered greater opportunities for tailored configurations, allowing organizations to adapt the system to their specific workflows and integration needs.

Regional Outlook

Region-wise, the Population Health Management Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded 44% revenue share in the market in 2024. In the North America region, the population health management market is experiencing significant growth. This is owing to the enhanced healthcare structure and larger acceptance of electronic health records. The market growth is prominent in nations such as the US due to their increased focus on lessening healthcare costs while enhancing patient outcomes. Also, the growing adoption of digital health platforms is resulting in expansion. Additionally, Europe region is projected to witness market opportunities in the forecast period. The growth in the European region is driven by government initiatives supporting healthcare digitalization, rising focus on preventive care, and deployment of PHM solutions to manage aging populations and chronic diseases.

The population health management market is expected to grow at a steady pace in the Asia Pacific region. This is because of the increasing concern of chronic diseases, rising healthcare expenditure, and prevalence of digital healthcare initiatives in nations such as Japan, India, and China. Rising investment in healthcare IT and government-led initiatives for healthcare are increasing acceptance. Moreover, the LAMEA market is predicted to have promising growth. This is because of the modernization in healthcare systems and increasing collaborations with global providers. Further, increasing demand for cost-effective and efficient care models is predicted to support the growth.

Recent Strategies Deployed in the Market

List of Key Companies Profiled

Global Population Health Management Market Report Segmentation

By Product

By Delivery Mode

By End-use

By Geography

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Market Trends - Population Health Management Market

Chapter 5. State of Competition - Population Health Management Market

Chapter 6. Product Life Cycle - Population Health Management Market

Chapter 7. Market Consolidation - Population Health Management Market

Chapter 8. Competition Analysis - Global

Chapter 9. Value Chain Analysis - Population Health Management Market

Chapter 10. Key Customer Criteria - Population Health Management Market

Chapter 11. Global Population Health Management Market by Product

Chapter 12. Global Population Health Management Market by Delivery Mode

Chapter 13. Global Population Health Management Market by End-use

Chapter 14. Global Population Health Management Market by Region

Chapter 15. Company Profiles

Chapter 16. Winning Imperatives of Population Health Management Market

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â